Roche Taps Integrated DNA Technologies for 454 GS FLX Fusion Primers | GenomeWeb
NEW YORK (GenomeWeb News) – The nucleic acid design and supply company Integrated DNA Technologies will provide Roche Diagnostics with fusion primers for some 454 sequencing applications, Roche said today.
 
The exclusive agreement calls for IDT to design, synthesize, and purify the primers for use with the 454 Genome Sequencer FLX System.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.